Jump to content

Editing EDéžå¤„æ–¹è¯ä¸Žä¿å¥å“:安全性ã€é£Žé™ 与€‰è´­æŒ‡å—

Revision as of 01:01, 17 October 2025 by IndianaDougherty (talk | contribs) (Created page with "<br><br><br>在第24周时,MED3000组61%的使用者表示勃起状态较基线有明显改善,国际勃起功能指数量表评分平均提高5.73分,并有85%的使用者表示"使用后可以出现自发性行为",并没有严重的不良事件。 Eroxon ®在美国获得 FDA 批准,在欧洲获得 CE 认证,在英国获得 UKCA Buy Rivotril 认证,作为 Eroxon ®品牌下针对成年男性勃起功能障碍的经临床证明的局部治疗...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Warning: You are editing an out-of-date revision of this page. If you publish it, any changes made since this revision will be lost.
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
Please note that all contributions to My wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see My wiki:Copyrights for details). Do not submit copyrighted work without permission!
Cancel Editing help (opens in new window)